Obviously, more data are needed to prove the tolerability of this treatment, but it seems that specific inhibition of PFKFB3 does not substantially interfere with physiological processes at the system level; therefore, it represents a promising target for cancer treatment. Here, PFKFB3 is linked to cancer.